Most Popular
AB InBev’s Growth Potential
Pricing Actions, Premiumization to Aid AB InBev’s (BUD) Growth
Anheuser-Busch InBev SA/NV BUD, commonly known as AB InBev, is geared up for expansion due to sustained consumer demand for its brand portfolio. The ...
TotalEnergies (TTE) Starts Producing From Mero Field Second Phase
Exciting Development: TotalEnergies (TTE) Commences Production in Mero Field’s Second Phase
TotalEnergies SE TTE has announced the commencement of production from the second development phase of the Mero field, situated on the Libra block over ...
Rare December Stock Selections from 34 Analysts
Rare December Stock Selections from 34 Analysts
December saw a recent market surge even higher, with the S&P 500 notching gains of nearly +14% over the final 2 months of 2023. ...
M-tron (MPTI) Hits 52-Week High: Here’s What’s Driving It
Record High for M-tron (MPTI)
M-tron Industries, Inc. (MPTI) reached a new 52-week high of $41.62 on Jan 3. The stock pulled back to end the trading session at ...
The Whirlwind Rise of Wabtec (WAB): A Glimpse into What Fuels the Growth
Strong Growth and Raised Guidance Wabtec Corporation (WAB) has found itself riding high on the crest of a lucrative wave, largely due to the ...
Unforeseen Challenges: A Review of REIT Holdings in 2023
Unforeseen Challenges: A Review of REIT Holdings in 2023
If I emphasized it once, I emphasized it a dozen times in December alone… 2023 took an unexpected turn, defying all earlier predictions. Approximately ...
Rare Stock Picks In December 2023 – From 34 Discerning Analysts
Hidden Gems Unearthed by 34 Sharp-Eyed Analysts
December witnessed the continuing surge in the market, featuring the S&P 500 with gains of nearly +14% over the final 2 months of 2023. ...
Why Myriad Genetics (MYGN) Stock is a Solid Retain
Why Myriad Genetics (MYGN) Stock is a Solid Retain
Myriad Genetics MYGN is poised for growth in the coming quarters, supported by a substantial improvement in testing volume across all its businesses. Despite ...
The Top 5 Dividend Stocks to Consider for 2024
By Sam Kovacs. Setting the Stage As we embark on this new era, it’s prime time to select a few gems. After all, what ...
Investors Eye ImmunoGen and GitLab Inc. for January 4th Surge
ImmunoGen, Inc. Shines Bright With Exciting Momentum Amidst the frenzy of the markets, investors are eagerly watching the exhilarating performance of ImmunoGen, Inc. (IMGN). ...
